| Structure | Chemical Name | CAS | MF |
|
2α-Deacetyl-5α-decinnamoyltaxagifin
|
135996-82-6
|
C26H36O11
|
|
Borate(1-), tetrakis(3-ethylphenyl)-, sodiuM(9CI)
|
135998-34-4
|
C32H37BNa-
|
|
Borate(1-), tetrakis(3-propylphenyl)-, sodiuM(9CI)
|
135998-35-5
|
C36H44BNa
|
|
Borate(1-), tetrakis(3-butylphenyl)-, sodiuM(9CI)
|
135998-36-6
|
C40H52BNa
|
|
4-(3-BROMO-PROPOXY)-BENZOIC ACID METHYL ESTER
|
135998-88-8
|
C11H13BrO3
|
|
2-BROMO-3-METHOXYPHENOL
|
135999-16-5
|
C7H7BrO2
|
|
Rosuvastatin Impurity 122
|
135999-58-5
|
C6H7ClO3
|
|
(S)-6-CHLOROMETHYL-5,6-DIHYDRO-PYRAN-2-ONE
|
135999-61-0
|
C6H7ClO2
|
|
8-(2-Hydoxyethylpiperazinyl)inosine
|
136003-94-6
|
C16H24N6O6
|
|
cyclo(5-hydroxytryptophyl-5-hydroxytryptophyl)
|
136004-14-3
|
C22H20N4O4
|
|
GALANIN (1-19) (HUMAN)
|
136005-51-1
|
C89H130N26O25
|
|
Benzenamine, N-cyclopropyl-4-fluoro- (9CI)
|
136005-64-6
|
C9H10FN
|
|
NARUMICIN I
|
136005-76-0
|
C37H66O7
|
|
L-4-THIAZOLYLALANINE
|
136010-41-8
|
C6H8N2O2S
|
|
2-(CyclopropylMethoxy)-benzoic acid
|
136013-76-8
|
C11H12O3
|
|
1,3-dichloro-1,1,2,3,3-pentafluoro-propane
|
136013-79-1
|
C3HCl2F5
|
|
FMOC-ARG(PMC)-OPFP
|
136013-81-5
|
C41H41F5N4O7S
|
|
(S)-3-Benzyl-4-(hydroxymethyl)-2-oxazolidinone
|
136015-39-9
|
C11H13NO3
|
|
(R)-(+)-4-(HYDROXYMETHYL)-2-OXAZOLIDINONE BENZOATE
|
136015-44-6
|
C11H11NO4
|
|
3-BROMOMETHYL-INDAN-1-ONE
|
136015-99-1
|
C10H9BrO
|
|
Butanoic acid, 3-oxo-, 2-(2-methyl-1-oxo-2-propenyl)oxyethyl ester, polymer with butyl 2-propenoate, ethenylbenzene, 2-hydroxyethyl 2-propenoate and methyl 2-methyl-2-propenoate
|
136016-63-2
|
C35H50O12
|
|
(2-HYDROXYPROPYL)-BETA-CYCLODEXTRIN
|
136019-12-0
|
C63H112O42
|
|
Tetradec-1-Yn-3-Ol
|
136022-04-3
|
C14H26O
|
|
2-Heptanone, 5-methyl-3-methylene-, (S)- (9CI)
|
136024-52-7
|
C9H16O
|
|
(2S,4R)-1-BOC-4-BENZYLOXY-PYRROLIDINE-2-DICARBOXYLIC ACID METHYL ESTER
|
136024-60-7
|
C18H25NO5
|
|
6-(3-chlorophenyl)-3-(4-pyridinyl)[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole
|
136025-40-6
|
C14H8ClN5S
|
|
Pyrazine, 3-methoxy-2-methyl-5-(1-methylpropyl)-, (S)- (9CI)
|
136025-81-5
|
C10H16N2O
|
|
4'-carbamoylpyridoxamine 5'-phosphate
|
136026-77-2
|
C9H14N3O6P
|
|
wistariasaponin G
|
136027-06-0
|
C49H76O20
|
|
N-Benzyloxycarbonyl-taurine sodium salt
|
136027-16-2
|
C10H14NNaO5S
|
|
(2-Sulfamoyl-ethyl)-carbamic acid benzyl ester
|
136027-17-3
|
C10H14N2O4S
|
|
Cyclopropanecarboxylic acid, cyclopropylidene-, ethyl ester (9CI)
|
136028-47-2
|
C9H12O2
|
|
(1R,2S)-1-Amino-2-indanol
|
136030-00-7
|
C9H11NO
|
|
(S)-(1-Methylpiperidin-2-yl)Methanol
|
136030-04-1
|
C7H15NO
|
|
FMOC-TIC-OH
|
136030-33-6
|
C25H21NO4
|
|
DL-2-(TRIFLUOROMETHYL)LEUCINE
|
136030-50-7
|
C7H12F3NO2
|
|
Ethanone, 1-(1,2-dihydroxycyclohexyl)-, (1R-trans)- (9CI)
|
136031-95-3
|
C8H14O3
|
|
Ethanone, 1-(1,2-dihydroxycyclohexyl)-, (1S-trans)- (9CI)
|
136031-96-4
|
C8H14O3
|
|
Isodesacetyluvaricin
|
136033-39-1
|
C37H66O6
|
|
Nexopamil
|
136033-49-3
|
C24H40N2O3
|
|
wistariasaponin D
|
136033-54-0
|
C47H74O17
|
|
Isoastragaloside IV
|
136033-55-1
|
C41H68O14
|
|
DERMASEPTIN
|
136033-70-0
|
C152H257N43O44S2
|
|
N-acetylglucosaminyl beta(1-6)N-acetylgalactosamine
|
136036-84-5
|
C16H28N2O11
|
|
5-chlorothiokynurenic acid
|
136036-87-8
|
|
|
tyrosyl-cyclo(ornithyl-phenylalanyl-prolyl-glycyl-)
|
136037-37-1
|
C30H38N6O6
|
|
1H-Indole-2-carboxylicacid,3-amino-4,5,6,7-tetrahydro-,ethylester(9CI)
|
136038-14-7
|
C11H16N2O2
|
|
1,3-phenylenebis((4-bromophenyl)methanone)
|
136039-69-5
|
C20H12Br2O2
|
|
S-(6-purinyl)-N-acetylcysteine
|
136039-99-1
|
C10H11N5O3S
|
|
S-(6-purinyl)homocysteine
|
136040-01-2
|
C9H11N5O2S
|
|
S-(6-purinyl)glutathione
|
136040-02-3
|
C15H19N7O6S
|
|
Trityl tetrakis(pentafluorophenyl)borate
|
136040-19-2
|
C43H15BF20
|
|
(3S,3aR,4aS,6aR,7R,9aS,9bS)-7-[(1S)-1-[(2R)-3,6-Dihydro-5-methyl-6-oxo-2H-pyran-2-yl]ethyl]decahydro-6a,9a-dimethyl-3-(1-methylethenyl)-1H-cyclopenta[a]cyclopropa[e]naphthalene-3a(4H)-propanoic acid
|
136040-43-2
|
C30H44O4
|
|
3′-O-Azidomethyl dT
|
136041-38-8
|
C11H15N5O5
|
|
FK 739
|
136042-19-8
|
C24H22N7Na
|
|
2-(3-Fluoro-4-methylphenyl)benzonitrile
|
136042-62-1
|
C14H10FN
|
|
BOS1 protein
|
136047-14-8
|
|
|
|
Max protein
|
136047-18-2
|
|
|
TETRAFLUORO-2-(PENTAFLUOROETHOXY)ETHANESULFONIC ACID TRIMETHYLSILYL ESTER
|
136049-37-1
|
C7H9F9O4SSi
|
|
FMOC-CYS(4-MBZL)-OH
|
136050-67-4
|
C26H25NO4S
|
|
N6-Ethyl-2'-deoxyadenosine
|
136050-93-6
|
C12H17N5O3
|
|
justiciresinol
|
136051-41-7
|
C21H26O7
|
|
nortrilobolide
|
136051-63-3
|
C26H36O10
|
|
3'-Hydroxy-5-methoxy-3,4-methylenedioxybiphenyl
|
136051-64-4
|
C14H12O4
|
|
3'-Hydroxy-5,5'-dimethoxy-3,4-methylenedioxybiphenyl
|
136051-65-5
|
C15H14O5
|
|
2-Pyrrolidinecarboxamide, 1-acetyl-, (R)- (9CI)
|
136051-77-9
|
C7H12N2O2
|
|
H-HIS-D-TRP-D-LYS-TRP-D-PHE-LYS-NH2
|
136054-22-3
|
C49H63N13O6
|
|
S4-(2-Cyanoethyl)-4-thio-2’-deoxyuridine
|
136055-15-7
|
C12H15N3O4S
|
|
β-D-Glucopyranoside, 2-(3-hydroxy-4-methoxyphenyl)ethyl, 4-[3-(4-hydroxy-3-methoxyphenyl)-2-propenoate], (E)-
|
136055-64-6
|
C25H30O11
|
|
L-PHENYLALANINE (2-13C)
|
136056-01-4
|
C9H11NO2
|
|
L-PHENYLALANINE (3-13C)
|
136056-02-5
|
C9H11NO2
|
|
R-3-hydroxyphenylglycine methyl ester hydrochloride
|
136057-18-6
|
C9H12ClNO3
|
|
protein kinase inhibitor M (6-24)
|
136058-51-0
|
C97H153N31O29
|
|
protein kinase inhibitor peptide (6-24)
|
136058-52-1
|
C90H141N31O29
|
|
[SER2]-NEUROMEDIN C
|
136058-54-3
|
C49H72N16O11S
|
|
Glycine, N-(diphenylMethylene)-
|
136059-92-2
|
C15H13NO2
|
|
N-(5-chloro-2-hydroxyphenyl)-4-methylbenzenesulfonamide
|
136061-90-0
|
C13H12ClNO3S
|
|
3-AMINO-3-(4-METHYLPIPERAZINO)ACRYLONITRILE
|
136062-62-9
|
C8H14N4
|
|
ETHYL 4-(1-AMINO-2-CYANOVINYL)TETRAHYDRO-1(2H)-PYRAZINECARBOXYLATE
|
136062-64-1
|
C10H16N4O2
|
|
1,2-Dioxolan-3-one, 5-ethyl-5-methyl-4-methylene-
|
136066-32-5
|
C7H10O3
|
|
(R)-3-methyl-3-(methylthio)-1-(1H-1,2,4-triazol-1-yl)-2-(4-(trifluoromethyl)phenyl)butan-2-ol(WX192352)
|
136067-84-0
|
C15H18F3N3OS
|
|
HEXAMETHYL-D18-DISILAZANE
|
136068-19-4
|
C6HD18NSi2
|
|
Acetic acid, [4-(1-oxo-3-phenyl-2-propenyl)phenoxy]-, (E)- (9CI)
|
136068-42-3
|
C17H14O4
|
|
Spiro[2H-1-benzopyran-2,4'-piperidine], methanesulfonamide deriv.
|
136079-82-8
|
C25H29N3O4S
|
|
1-Benzoyl-4-benzylpiperidine-4-carboxylic acid
|
136080-23-4
|
C20H21NO3
|
|
spiro[indene-2,4'-piperidin]-1(3H)-one
|
136080-25-6
|
C13H15NO
|
|
2,1,3-Benzoxadiazole-5-ethanol
|
136080-71-2
|
C8H8N2O2
|
|
4-(aminomethyl)Benzeneethanol
|
136081-18-0
|
C9H13NO
|
|
6-OXO-5,6,7,8-TETRAHYDRO-NAPHTHALENE-2-CARBONITRILE
|
136081-50-0
|
C11H9NO
|
|
1H-Indole, 1-acetyl-5-ethenyl-2,3-dihydro- (9CI)
|
136081-56-6
|
C12H13NO
|
|
1-BENZOYL-PIPERIDINE-4-CARBOXYLIC ACID ETHYL ESTER
|
136081-74-8
|
C15H19NO3
|
|
SPIRO[CHROMENE-2,4'-PIPERIDIN]-4(3H)-ONE
|
136081-84-0
|
C13H15NO2
|
|
(1S,2R,3R)-1,2,3,4-Tetrahydro-7-hydroxy-1-(4-hydroxy-3-methoxyphenyl)-6,8-dimethoxy-2,3-naphthalenedimethanol
|
136082-41-2
|
C21H26O7
|
|
N-myristoyl-arginyl-lysyl-arginyl-threonyl-leucyl-arginyl-arginyl-leucine
|
136082-43-4
|
C60H119N21O10
|
|
FMOC-D-ASP-OH
|
136083-57-3
|
C19H17NO6
|
|
FMoc-DL-serine
|
136083-72-2
|
C18H17NO5
|
|
FMoc-DL-aspartic acid
|
136083-73-3
|
C19H17NO6
|
|
Fmoc-DL-glutamic acid
|
136083-74-4
|
C20H19NO6
|
|
1,2,3-Trimethoxy-7-hydroxyxanthone
|
136083-92-6
|
C16H14O6
|
|
2,7-Dimethoxy-1,3,6-trihydroxyxanthone
|
136083-93-7
|
C15H12O7
|